It's very close! First patient dosed is a significant milestone, and achieving it rapidly after governance highlights clinician interest in the trial and should drive positive sentiment. The patent clock ticking alongside the countdown to data! Let's go!
RAC
race oncology ltd
Add to My Watchlist
5.31%
!
$1.19

General Comments / Chat, page-12974
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.19 |
Change
0.060(5.31%) |
Mkt cap ! $206.7M |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.14 | $204.7K | 175.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 8000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20 | 1.180 |
1 | 6470 | 1.160 |
2 | 2866 | 1.150 |
2 | 21477 | 1.140 |
3 | 15247 | 1.130 |
Price($) | Vol. | No. |
---|---|---|
1.195 | 8000 | 1 |
1.200 | 2500 | 1 |
1.210 | 6800 | 1 |
1.250 | 3254 | 2 |
1.350 | 1648 | 1 |
Last trade - 15.50pm 17/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online